Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 261
Filter
1.
China Journal of Orthopaedics and Traumatology ; (12): 185-188, 2023.
Article in Chinese | WPRIM | ID: wpr-970844

ABSTRACT

OBJECTIVE@#To improve the rat model of cervical spondylosis of vertebral artery type (CSA) induced by injecting sclerosing agent. To evaluate the efficacy of injecting sclerosing agent to induce CSA.@*METHODS@#Forty Health SPF SD rats(20 males and 20 females), were randomly divided into two groups:the model group (20) and the blank group (20). All the animals were followed up for 4 weeks for the observation of general situation, transcranial Doppler(TCD) detection of blood flow velocity, pulsatility index and resistive index of the vertebral artery, measurement of mental distress by open-field test.@*RESULTS@#One to two days after establish the animal model, rats in the model group appeared apathetic with decreased autonomic activities, trembling, squinting, increased eye excrement, etc., and no rats died during the experiment. The mean blood flow velocity of the model group was lower than that of the blank group (P<0.05), and the pulsatilit index and resistive index of the model group were higher than that of the blank group (P<0.05). The mental distress of the model group was significantly higher than that of the blank group.@*CONCLUSION@#The modified injection of sclerosing agent is a practical method to establish the rat model of CSA, with high success rate, high stability, low mortality and simple operation.


Subject(s)
Male , Animals , Female , Rats , Sclerotherapy , Sclerosing Solutions/therapeutic use , Rats, Sprague-Dawley , Spondylosis/therapy , Spine , Vertebral Artery
2.
Journal of Biomedical Engineering ; (6): 353-358, 2022.
Article in Chinese | WPRIM | ID: wpr-928232

ABSTRACT

Foam stability affects the efficacy and incidence of side effects of foam sclerotherapy. Exploring the relationship between foam pressure difference and foam stability can provide ideas and basis for obtaining more stable foam. In the experiment, sodium cod liver oleate foam was selected, and poloxamer 188 (concentration of 0%, 4%, 8%, 12%) was added to realize the change of foam pressure. By using the self-written program to process the foam pictures, the foam pressure difference and the relationship between the foam stability indicators (water separation rate curve, half-life) and the foam pressure difference were obtained. The results showed that at first the foam pressure increased with the increase of the concentration, and then it decreased with the increase of the concentration and reached a peak at the concentration of 4%. The foam pressure difference decreases continuously with the increase of decay time. When the additive concentration is low, the foam average pressure difference increases. And if the additive concentration is too high, the foam average pressure difference decreases. The smaller the foam pressure difference is, the better the foam stability is. This paper lays a foundation for the research on the stability of foam hardener.


Subject(s)
Humans , Half-Life , Poloxamer , Sclerosing Solutions/adverse effects , Sclerotherapy , Varicose Veins
4.
Rev. guatemalteca cir ; 27(1): 10-12, 2021. tab
Article in Spanish | LILACS, LIGCSA | ID: biblio-1371866

ABSTRACT

Insuficiencia venosa es definida como la patología que causa síntomas en los miembros inferiores, incluyendo edema, hiperpigmentación, lipodermatoesclerosis y ulceración e implica una anormalidad funcional del sistema venoso. Objetivo: Se compararon los resultados en cuanto a complicaciones y satisfacción reportada por las pacientes, con la Escleroterapia con Polidocanol utilizando aire y agua como diluyente. Métodos: Se incluyeron en el estudio a 60 pacientes del sexo femenino con diagnóstico de Insuficiencia Venosa Superficial CEAP C1, divididas en dos grupos, a las cuales se les aplicó Escleroterapia con Polidocanol mezclado con agua y aire. Se realizó seguimiento durante cuatro semanas donde se recogió la información del paciente con respecto a la mejoría de los síntomas antes de iniciar el tratamiento y los efectos adversos del Polidocanol con ambas terapias. Resultados: Dentro de las complicaciones de ambos tratamientos únicamente fue reportado el Matting en rango leve durante la primera semana. El único síntoma reportado como severo fue Dolor en la escleroterapia con polidocanol mezclado con aire. Los demás signos síntomas fueron reportados dentro del rango de moderado el cual descendió hasta leve entre la segunda y tercera semana, no encontrando reportes a la cuarta semana. La única complicación reportada fue el Matting en la escleroterapia con polidocanol mezclado con aire. Conclusión: No se encontraron diferencias significativas en grado de satisfacción con la eficacia del tratamiento, los efectos adversos, la forma en que se administra el medicamento entre ambos tratamientos de escleroterapia, oscilando los rangos de satisfacción entre el 43 al 70%. (AU)


Venous insufficiency is defined as the pathology that causes symptoms in the lower limbs, including edema, hyperpigmentation, lipodermatosclerosis and ulceration and implies a functional abnormality of the venous system. Objective: The results in terms of complications and satisfaction reported by the patients were compared with Sclerotherapy with Polidocanol using air and water as diluent. Methods: 60 female patients with a diagnosis of Superficial Venous Insufficiency CEAP C1 were included in the study, divided into two groups, to which Sclerotherapy with Polidocanol mixed with water and air was applied. A follow-up was carried out for four weeks where information from the patient was collected regarding the improvement of symptoms before starting treatment and the adverse effects of Polidocanol with both therapies. Results: Within the complications of both treatments, only Matting was reported in a mild range during the first week. The only symptom reported as severe was pain in sclerotherapy with polidocanol mixed with air. The other signs and symptoms were reported within the moderate range, which decreased to mild between the second and third week, finding no reports at the fourth week. The only complication reported was Matting in sclerotherapy with polidocanol mixed with air. Conclusion: No significant differences were found in the degree of satisfaction with the efficacy of the treatment, the adverse effects, the way in which the drug is administered between both sclerotherapy treatments, the satisfaction ranges ranging from 43 to 70%. (AU)


Subject(s)
Humans , Female , Sclerosing Solutions/therapeutic use , Venous Insufficiency/therapy , Sclerotherapy/methods , Polidocanol/therapeutic use , Sclerosing Solutions/adverse effects , Sclerotherapy/adverse effects , Treatment Outcome , Hyperpigmentation/chemically induced , Lower Extremity/blood supply , Polidocanol/adverse effects
5.
Rev. méd. Chile ; 148(11)nov. 2020.
Article in Spanish | LILACS | ID: biblio-1389251

ABSTRACT

In patients with actively bleeding gastric varices, the treatment of choice is the endoscopic use of sclerosing agents such as cyanoacrylate. We report a 69-year-old man who, after being treated with cyanoacrylate, suffered from recurrent febrile episodes. After an extensive study and broad-spectrum antibiotic treatment, discarding other presumably infectious focus, the superinfection of the cyanoacrylate plug was suspected, and its surgical removal was decided. A partial gastrectomy of the gastric fundus, a splenectomy, and a distal pancreatectomy were performed. The patient evolved without fever and without new episodes of bacteremia, but with decompensation of his cirrhosis manifested by ascites, spontaneous bacterial peritonitis, pneumonia, and collections in the pancreatic bed. These complications were managed with medical treatment consisting in a long course of broad-spectrum antibiotics. Thereafter, the patient evolved satisfactorily.


Subject(s)
Aged , Humans , Male , Esophageal and Gastric Varices , Cyanoacrylates , Sclerosing Solutions/therapeutic use , Gastrointestinal Hemorrhage/drug therapy , Liver Cirrhosis
7.
Ibom Medical Journal ; 13(3): 180-186, 2020. tab
Article in English | AIM | ID: biblio-1262929

ABSTRACT

Background: In the West African sub-region, significant morbidity and mortality are known to affect patients with malignant pleural effusion (MPE) but are highly under reported unlike USA, Europe or South Africa. Aim/Objective: To review cases of MPE in our tertiary hospital in the last 13 years with a view to determining the challenges and prospects. Materials and Method: This is a retrospective study spanning over a decade from January, 2007 to December, 2019. Malignant pleural effusion from various neoplasms constitutes the commonest thoracic malignancy in our tertiary hospital. After 13 years of management of such patients, we reviewed the datafrom the hospital record's department. The data obtained were demography, aetiology, total number of pleural fluid specimens for cytology and pleural biopsies submitted for histology, pleurodesis and other treatment modalities. Result: 211 patients with MPE were admitted and managed during the period under review. Of these numbers, 135(64.0%) were confirmed cytologically positive (MPE). 76(36.0%) tested falsely negative and were initially regarded as paramalignant, later confirmed MPE. The age affected was from 7 to 81 years with a mean of 44 years. Of 211 patients with MPE, 94 were males while 117 were females, with a male to female ratio of 4:5. Aetiologically, metastatic breast cancer was the highest followed by advance lung cancer. Conclusion: Submission of insufficient samples resulted in false negative cytology. Review of recurrent pleural effusion and exophytic tumour at the sites of CTTD resulted in late diagnosis of MPE. Additionally, prolonged hospital stay awaiting CTTD and cytology results are among the challenges


Subject(s)
Nigeria , Pleural Effusion, Malignant , Pleurodesis , Sclerosing Solutions , Tertiary Care Centers
8.
Int. j. odontostomatol. (Print) ; 14(3): 373-379, 2020. tab, graf
Article in English | LILACS | ID: biblio-1114910

ABSTRACT

Benign oral vascular lesions are anomalies characterized by the blood vessels proliferation or malformation and the treatment with the sclerosing agent ethanolamine oleate acts irrigating the vessel producing a sterile inflammatory response. The objective of this study was to report and discuss the results from treatment of benign oral vascular lesions with non-diluted ethanolamine oleate through the analysis of clinical records. The sample was composed by the selection of twenty-six patients (12 male and 14 female), with oral vascular malformations. All lesions were treated with intralesional injections of undiluted ethanolamine oleate. These patients attended in Oral Medicine outpatient clinic of the Federal University of Paraná between the years of 2011 to 2015. The average age was 60.65 years, with a higher prevalence for women. The majority of the individuals had one lesion and its location was mostly in the lower lip. The main complaint was about a physical discomfort. The lesions had the average size of 6.52 mm and received a median number of 2.32 applications. Only one patient reported feeling pain in the postoperative week. In most cases the resolution of the lesion was considered partial. Follow-up was obtained up to one month after the end of treatment. The sclerotherapy with undiluted ethanolamine oleate shows acceptable results in the treatment of small benign oral vascular lesions with a few minor side effects.


Las lesiones vasculares orales benignas son anomalías caracterizadas por la proliferación o malformación de los vasos sanguíneos y el tratamiento con el agente esclerosante etanolamina oleato actúa irrigando el vaso produciendo una respuesta inflamatoria estéril. El objetivo de este estudio fue informar y discutir los resultados del tratamiento de lesiones vasculares orales benignas con oleato de etanolamina no diluido a través del análisis de historias clínicas. La muestra estuvo compuesta por la selección de veintiséis pacientes (12 hombres y 14 mujeres), con malformaciones vasculares orales. Todas las lesiones fueron tratadas con inyecciones intralesionales de oleato de etanolamina sin diluir. Estos pacientes acudieron a la clínica ambulatoria de Medicina Oral de la Universidad Federal de Paraná entre los años 2011 a 2015. La edad promedio fue de 60,65 años, con una mayor prevalencia para las mujeres. La mayoría de los individuos tenían una lesión y su ubicación era principalmente en el labio inferior. La queja principal era sobre una molestia física. Las lesiones tenían un tamaño promedio de 6,52 mm y recibieron una mediana de 2,32 aplicaciones. Solo un paciente informó haber sentido dolor en la semana postoperatoria. En la mayoría de los casos, la resolución de la lesión se consideró parcial. El seguimiento se obtuvo hasta un mes después del final del tratamiento. La escleroterapia con oleato de etanolamina sin diluir muestra resultados aceptables en el tratamiento de pequeñas lesiones vasculares orales benignas con algunos efectos secundarios menores.


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Aged , Young Adult , Oleic Acids/administration & dosage , Sclerotherapy/methods , Ethanolamine/administration & dosage , Vascular Malformations/therapy , Mouth Diseases/therapy , Sclerosing Solutions/administration & dosage , Blood Vessels/abnormalities , Mouth Neoplasms/therapy , Injections, Intralesional , Follow-Up Studies , Treatment Outcome , Patient Satisfaction , Hemangioma/therapy , Lip/blood supply
9.
An. bras. dermatol ; 94(5): 521-526, Sept.-Oct. 2019. tab, graf
Article in English | LILACS | ID: biblio-1054866

ABSTRACT

Abstract Background The use of monoethanolamine oleate 5% is effective for the treatment of vascular malformations with low blood flow. Objectives To report a case series of vascular malformations in the mouth and oral cavity treated with monoethanolamine oleate 5%. Methods A retrospective descriptive study was performed in electronic patient charts covering seven years. Patient demographics, diagnostic resources, lesion site, size, and number of applications of monoethanolamine oleate 5% were collected. Results A total of 21 vascular malformations were recorded, located mostly on the lower lip (52.3%) and resolved in a single application in 14 patients. The authors found 19 patients treated with sclerotherapy. Thirteen were women and six were men, with a mean age of 61 years. Study limitation Small sample size. Conclusions Sclerotherapy is an effective treatment for vascular malformations of the lips and oral cavity, with resolution after only one or two applications (n = 16).


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Sclerosing Solutions/administration & dosage , Oleic Acids/administration & dosage , Sclerotherapy/methods , Vascular Malformations/therapy , Mouth Diseases/therapy , Time Factors , Injections, Intralesional , Retrospective Studies , Treatment Outcome , Esthetics , Lip/blood supply , Lip/pathology , Mouth Diseases/pathology
10.
Paraguay Oral Research ; 8(1): 47-54, julio 2019.
Article in Spanish | BDNPAR, LILACS | ID: biblio-1021725

ABSTRACT

El hemangioma, según la Organización Mundial de la Salud (OMS), es una neoplasia vascular benigna, caracterizada por la proliferación anormal de vasos sanguíneos, se presenta como una lesión única, pudiéndose observar en cualquier parte del organismo, sin embargo es más incidente en el área de cabeza y cuello, con predominio en los labios, en la lengua y en la mucosa yugal. Técnicamente, su exrpación quirúrgica es dicil y desafiante, al estar cargada con complicaciones como hemorragia, escisión incompleta, desfiguración facial y recurrencia. Objevo: relatar el caso clínico de un paciente con hemangioma lingual tratado con Polidocanol al 0,5%. Se necesitaron de 4 sesiones de aplicación del agente esclerosaste para que retrocediera completamente la lesión donde en cada infiltración se ulizó 1ml y en la úlma sesión 0.7 ml, logrando en esta úlma obtener la desaparición de la lesión por lo que el pronósco fue bueno. Conclusión: De acuerdo a los resultados de este trabajo el uso del Polidocanol al 0.5% en tratamientos de hemangioma linguales resulta ser una técnica bastante efecva, ya que con su prácca nos da una disminución del volumen de dicha lesión


The hemangioma, according to theWorldHealthOrganizaon (WHO), is a benign vascular neoplasm, characterized by the abnormal proliferaon of blood vessels, it presents as a single lesion, it can be found anywhere in the body, however it is more incident in thearea of the head and neck, predominantlyonthelips, onthetongue and onthejugal mucosa. Technically, its surgical removal is difficult and challenging, incomplete disease, facial disfigurement and recurrence. Objecve: to report the clinical case of a paentwith lingual hemangioma treatedwith 0.5% Polidocanol. iook 4 sessions of applicaon of thesclerosingagent to completelyretrachelesionwhere 1 ml wasused in eachinfiltraon and 0.7 ml in thelastsession, obtainingthedisappear of thelesion in thelaer, so the prognosis wasgood. Conclusion: According to the results of this study, the use of Polidocanol at 0.5% in lingual hemangioma treatmentsis a very effecve technique, and with its pracce we have a decrease in the volume of this lesion


Subject(s)
Humans , Female , Middle Aged , Sclerosing Solutions/therapeutic use , Tongue Neoplasms/drug therapy , Polidocanol/therapeutic use , Hemangioma/drug therapy , Sclerosing Solutions/administration & dosage , Polidocanol/administration & dosage
11.
Neurointervention ; : 53-60, 2019.
Article in English | WPRIM | ID: wpr-741673

ABSTRACT

PURPOSE: We analyzed results of percutaneous sclerotherapy for venous malformations (VMs) in head, neck and extremities. MATERIALS AND METHODS: Thirty-five patients with head and neck and extremities VM treated by sclerotherapy with bleomycin and sodium tetradecyl sulphate (STS) were retrospectively reviewed. A pre-treatment magnetic resonance imaging was done for all patients to diagnose the lesion. Each lesion received 1 to 11 sessions (average, 2.7; standard deviation [SD], 2.03). We evaluated percentage reduction in swelling size and a Likert scale review of subjective feelings of the patients. RESULTS: Sixteen had a complete obliteration; by sclerotherapy alone (n=13) and surgery after a 75% reduction (n=3). Ten patients had a significant reduction up to 75% and three patients by 50%. Four had a minimal decrease with reduction of 25% or less. Follow-up duration of the patients varied from a minimum of 6 months up to 3 years (average, 15.7 months; SD, 7.8 months). Of all patients, three refused further treatment and were lost to follow-up, while another two were referred to a dermatologist. Thirteen patients reported feeling excellent after the sessions. Eight patients claimed to feel slightly better compared to before the sessions started. Only three patients complained of feeling the same before and after the sessions. None of the patients still in follow-up have reported a recurrence of a lesion thus far. CONCLUSION: Sclerotherapy using bleomycin and STS as sclerosants is a safe and effective primary treatment for VMs in the head and neck as well as in extremities.


Subject(s)
Humans , Bleomycin , Extremities , Follow-Up Studies , Head , Lost to Follow-Up , Magnetic Resonance Imaging , Neck , Recurrence , Retrospective Studies , Sclerosing Solutions , Sclerotherapy , Sodium , Vascular Malformations
12.
urol. colomb. (Bogotá. En línea) ; 28(1): 70-75, 2019. ilus
Article in Spanish | LILACS, COLNAL | ID: biblio-1402275

ABSTRACT

Introducción Reportar el caso de un paciente con lipogranuloma esclerosante de pene llevado a corrección de curvatura peneana compleja, con injerto de espesor parcial y posterior retracción secundaria, que generó curvatura peneana impidiendo el coito y que al momento de corrección quirúrgica, se generó un defecto de cubrimiento dérmico que requirió el uso de colgajo con piel de la pared abdominal. Materiales y Métodos Hombre de 46 años con antecedente de resección de lipogranuloma esclerosante en cara dorsal del pene resecado en el año 2006 y disfunción eréctil en manejo con terapia intracavernosa con prostaglandina E2; con necesidad de injertos de piel de abdomen en 2 oportunidades para cubrimiento de defecto de piel, con posterior fibrosis y curvatura peneana dorsal de aproximadamente 60° asociado a dolor con la erección. Llevado a corrección de curvatura peneana compleja en Hospital Universitario Mayor- Méderi. Se realiza plicatura de la túnica albugínea con técnica de Yachia hasta la verificación de corrección de curvatura dorsal en un 90%. Se identifica área con defecto de cubrimiento, por lo cual se levanta colgajo en región hipogástrica abdominal y se realiza anclaje del colgajo en borde distal del defecto de cubrimiento. Seis semanas después, es llevado a segundo tiempo quirúrgico, con liberación y remodelación del colgajo y se realiza el anclaje del colgajo en el borde proximal del defecto. Tres meses después, se revalúa el paciente encontrándose cubrimiento completo del área cruenta en región dorsal del pene. Se induce erección con alprostadil intracavernoso evidenciándose curvatura peneana dorsal de menos de 5°. Discusión Los pacientes con lipogranuloma esclerosante del pene generan placas en túnicas peneanas que al momento de ser resecadas, pueden requerir el uso de segmentos de piel para cubrimiento con injertos o colgajos pediculados en un terreno con alta probabilidad de daño por isquemia de dichos tejidos. En los casos en los que ocurre contracción del injerto se generan curvaturas peneanas que en caso de que impidan el coito requieren corrección de la misma. El uso de injertos autólogos o aloinjertos ha presentado resultados satisfactorios, sin embargo, puede requerir dos tiempos quirúrgicos para la obtención de tejido. En pacientes en quienes la piel peneana no es suficiente para cubrir el defecto, la segunda opción es la piel escrotal, que conserva características similares, así como una excelente vascularización. Cuando no se cuenta con piel escrotal en buen estado, se usa un injerto de piel de espesor total como última opción con resultados satisfactorios. Conclusiones Actualmente, el uso de piel de abdomen en esos defectos de piel no tiene amplia acogida dada la presencia de anexos dérmicos que terminan generando un aspecto estético no óptimo, sin embargo, se evidencia en este caso, que es un tejido que se adapta fácilmente a su nueva ubicación y permite el fin último, que es lograr una adecuada función del órgano receptor.


Introduction Report the case of a patient with penile sclerosinglipogranuloma who was taken to corrrection of complex penile curvature with split-thickness graft with later secondary retraction that caused penile curvature preventing intercourse and during surgical mangement generated a skin coverge defect that required the use of free skin flap from the abdominal wall. Material and Methods 46 year old men with a history of surgical resection of sclerosinlipogranuloma in dorsal penile resected in 2006 and erectile dysfunction managed with intracavernous therapy with prostaglandin E2; that required abdominal skin grafts in 2 opportunities for skin defect coverage, with subsequent fibrosis and dorsal penile curvature of ∼60 degrees associated with pain during erection. Carried complex penile curvature correction in Hopsital Universitario Mayor ­ Méderi. Plication of the tunica albuginea with Yachia technique is performed until correction of dorsal curvature in 90%. Coverage defect area is identified, so that flap of hypogastric abdominal region is lifted and anchored in the distal edge of coverage defect. 6 weeks later is taken to second surgical procedure, with release and remodeling of the flap and anchorage of it in the proximal edge of the defect. 3 months after, the patient is reassessed finding complete coverage of the area on the dorsal surface of the penis. Erection is induced by intracavernousalprostadil showing dorsal penile curvature of less than 5 degrees. Discussion Patients with sclerosing penile lipogranuloma undergo plaques in penile layers that when resected may require the use of skin grafts or pedicle flaps for coverage in an area with high probability of ischemia in these tissues. In cases in which the graft contraction result in penile curvature, that in the event of preventing coitus require surgical correction thereof. The use of autologous grafts or allografts have shown satisfactory results, but may require two surgical procedures to obtain adecuate tissue. In patients in whom the penile skin is not enough to cover the defect, the second option is scrotal skin, which retains similar characteristics, as well as an excellent vascularization. When there is no adecuate scrotal skin, full thickness skin grafting as last option is used with satisfactory results. Conclusions Currently, the use of abdominal skin in these skin defects has no wide acceptance because of the presence of dermal annexes, ending in a suboptimal aesthetic appearance, however, it is evident in this case, is a tissue that is easily adapted to its new location and allows the latter, which is to achieve adequate organ receptor function.


Subject(s)
Humans , Male , Middle Aged , Penis , Skin Transplantation , Free Tissue Flaps , Allografts , Penis/surgery , Sclerosing Solutions , Surgical Procedures, Operative , Alprostadil , Dinoprostone , Coitus , Transplants , Erectile Dysfunction
13.
RFO UPF ; 23(3): 315-321, 18/12/2018. ilus
Article in Portuguese | LILACS, BBO | ID: biblio-995385

ABSTRACT

O hemangioma é uma neoplasia de comportamento benigno, determinada pela proliferação anormal de vasos sanguíneos. São lesões assintomáticas, porém, seu crescimento progressivo pode acarretar danos traumáticos locais, ocasionando dor, ulcerações e até sangramentos, que, dependendo da localização, se tornam de difícil controle, principalmente quando de natureza arterial. Com considerável incidência na região de cabeça e pescoço e na cavidade bucal, acomete mais frequentemente a região de mucosa jugal, lábios e língua. Tendo em vista a sua relevância clínica, por estar presente na sua área de atuação e ser relativamente comum, o conhecimento acerca dessa neoplasia benigna é de fundamental importância ao cirurgião-dentista. Entre os recursos terapêuticos, a escleroterapia química tem sido empregada, apresentando resultados satisfatórios tanto clínicos quanto estéticos. Objetivo: apresentar as características clínicas do hemangioma, os métodos de diagnóstico e o tratamento realizado por meio de escleroterapia química. Relato de caso: são descritos dois casos clínicos de hemangiomas, diagnosticados em duas pacientes do sexo feminino, localizados um em lábio superior e outro em mucosa jugal, tratados por meio de injeção de solução esclerosante. Considerações finais: em ambos os casos, foi possível proporcionar a involução das lesões mediante procedimentos não cirúrgicos, favorecendo, no período pós-operatório, o conforto e a estética, demonstrando a eficiência e a segurança na utilização do oleato de monoetanolamina a 5% (Ethamolin ®). (AU)


Hemangioma is a neoplasm of benign behavior, determined by abnormal proliferation of blood vessels. They are asymptomatic lesions, however, their progressive growth can cause local traumatic injuries, causing pain, ulcerations and even bleeding, which, depending on the location, becomes difficult to control, especially when of an arterial nature. With a considerable incidence in the head and neck region, in the oral cavity, it most frequently affects the region of jugal mucosa, lips and tongue. Due to its clinical relevance, because it is present in the area of practice of the dental surgeon and is relatively common, knowledge about this benign neoplasm is of fundamental importance. Among the therapeutic resources, chemical sclerotherapy is employed presenting satisfactory clinical and aesthetic results. Objective: the purpose of this study is to present the clinical characteristics of hemangioma, the diagnostic methods and the treatment performed through chemical sclerotherapy. Case report: this article describes the description of two clinical cases of hemangiomas diagnosed in two female patients, one located in the upper lip and the other in the jugal mucosa treated with sclerosing solution injection. Final considerations: in both cases, it was possible to provide the involution of the lesions by non-surgical procedures, favoring, in the postoperative period, comfort and aesthetics, demonstrating the efficiency and safety in the use of 5% monoethanolamine oleate (Ethamolin®). (AU)


Subject(s)
Humans , Female , Child , Adult , Lip Neoplasms/therapy , Sclerotherapy/methods , Hemangioma/therapy , Mouth Mucosa , Sclerosing Solutions/therapeutic use , Oleic Acids/therapeutic use , Treatment Outcome
14.
J. vasc. bras ; 17(4): 333-336, out.-dez. 2018. ilus
Article in Portuguese | LILACS | ID: biblio-969174

ABSTRACT

Cerebral ischemia is a very rare and harmful complication of ultrasound-guided foam sclerotherapy for treatment of varicose veins. This case describes a documented cerebrovascular ischemia in Broca's area following ultrasound-guided foam sclerotherapy. Less than one hour after intravenous injection of 10 ml of sclerosing foam, an otherwise healthy woman experienced aphasia without any other signs of neurological changes. When she arrived home, a complete inability to talk was observed. The event was misdiagnosed by another doctor as an allergic reaction. Next morning she came to the office to report the allergic reaction, where an appropriate diagnosis was made. She recovered just two days after the injection, but signs of recent cerebral ischemia were seen in Broca's area on magnetic resonance and transesophageal bubble study echocardiogram revealed a patent foramen ovale. Although rare, we must make great effort to prevent these events instead of treating them


A isquemia cerebral é uma complicação muito rara e perigosa da escleroterapia com espuma guiada por ultrassom no tratamento de varizes. Este caso descreve uma isquemia cerebral da área de Broca após escleroterapia com espuma guiada por ultrassom. Menos de uma hora após injeção de 10 mL de espuma, uma até então saudável mulher apresentou afasia, sem quaisquer outros sinais neurológicos. No caminho para casa, uma completa incapacidade de fala foi observada. Levada ao hospital mais próximo, foi diagnosticada com reação alérgica. Na manhã seguinte, compareceu ao consultório para relatar a reação alérgica, quando um correto diagnóstico foi feito. Ela ficou recuperada dois dias depois do procedimento, mas uma ressonância magnética mostrou sinais de isquemia recente da área de Broca e um ecocardiograma transesofágico mostrou um forame oval patente. Embora raros, devemos concentrar nossos esforços em prevenir tais eventos para que não precisem de tratamento


Subject(s)
Humans , Female , Ultrasonics/methods , Sclerotherapy , Brain Ischemia/complications , Sclerosing Solutions/therapeutic use , Varicose Veins/therapy , Magnetic Resonance Spectroscopy/methods , Echocardiography, Transesophageal/methods , Embolism/complications , Foramen Ovale, Patent
15.
J. vasc. bras ; 17(4): 341-347, out.-dez. 2018. ilus
Article in Portuguese | LILACS | ID: biblio-969241

ABSTRACT

A escleroterapia continua sendo um dos procedimentos mais executados pelos cirurgiões vasculares brasileiros. O conhecimento das suas complicações é imprescindível para que possamos evitá-las. Os efeitos colaterais graves desse método de tratamento para as telangiectasias dos membros inferiores são raros e frequentemente associados a um erro técnico ou à dosagem injetada. São predominantemente locais, apresentando-se, algumas vezes, como uma situação de difícil resolução. Relatamos um caso de formação de necrose cutânea após escleroterapia química com glicose hipertônica (75%) e sua cicatrização utilizando preparação tópica contendo vaselina e glicose 60%, cujo resultado estético foi satisfatório


Sclerotherapy remains one of the procedures most frequently performed by Brazilian vascular surgeons. Knowledge of its complications is indispensable to enable us to avoid them. The severe side effects of this method of treatment for telangiectasias of the lower limbs are rare and are often associated with technical errors or the dose injected. Complications are predominantly local, but are sometimes difficult to resolve. We report a case of formation of cutaneous necrosis after chemical sclerotherapy using hypertonic glucose (75%), which healed when treated with a topical preparation containing vaseline and 60% glucose, with satisfactory esthetic results


Subject(s)
Humans , Female , Middle Aged , Telangiectasis/diagnosis , Glucose , Necrosis/complications , Petrolatum/therapeutic use , Sclerosing Solutions/therapeutic use , Skin Ulcer/diagnosis , Skin Ulcer/therapy , Varicose Veins/therapy , Wound Healing , Fibrosis , Sclerotherapy/methods , Echocardiography, Doppler, Color/methods , Lower Extremity , Erythema
16.
Acta cir. bras ; 33(9): 785-791, Sept. 2018. graf
Article in English | LILACS | ID: biblio-973499

ABSTRACT

Abstract Purpose: To evaluate the morphological effects of injected sclerosing agents into the liver. Methods: This study was performed on twenty dogs, distributed into five groups: Group 1 (n = 5) - control, Group 2 (n = 5) - injection of 50% glucose solution inside hepatic parenchyma and animals followed during seven days, Group 3 (n = 10) - injection of ethanol inside hepatic parenchyma and animals distribution into two subgroups Subgroup 3A (n = 5) - followed during 24 hours and subgroup 3B (n = 5) - followed during seven days (group 3B), Group 4 (n = 5) - ethanol injection inside left portal vein branch and followed during 24 hours. Livers were macroscopically evaluated, submitted to hepatic arteriography and portography, then histology. Results: All animals in Group 4 died within 23 hours due to diffuse hepatic necrosis. The animals of groups 2 and 3 had a satisfactory evolution. Fibrosis formed in the segment reached by the sclerosant solution and interruption of the contrast flow injected into the portal system. Conclusion: Intrahepatic parenchymal ethanol injection is well tolerated and causes sclerosis restricted to a specific segment; however, intraportal ethanol injection causes massive hepatic necrosis and can lead to death.


Subject(s)
Animals , Male , Dogs , Portal Vein/drug effects , Liver/drug effects , Portal Vein/pathology , Portal Vein/diagnostic imaging , Sclerosing Solutions/pharmacology , Sclerosis/chemically induced , Sclerosis/pathology , Sclerosis/diagnostic imaging , Portography , Liver/pathology , Liver/diagnostic imaging
17.
ImplantNewsPerio ; 3(3): 518-526, mai.-jun. 2018. ilus
Article in Portuguese | LILACS, BBO | ID: biblio-905519

ABSTRACT

O hemangioma é considerado como uma neoplasia vascular benigna, caracterizado por uma fase de crescimento rápido, com proliferação de células endoteliais, seguida por uma estabilização gradual. A principal queixa dos pacientes portadores dessa neoplasia é referente à estética e, por esse motivo, a escleroterapia vem sendo uma boa opção de tratamento para obter resultados estéticos satisfatórios. Para esse tipo de tratamento, são utilizadas aplicações com oleato de monoetanolamina a 0,05 g/ml (Ethamolin), que promovem a regressão da lesão por fibrose dos espaços endoteliais. No presente artigo, é descrito um relato de caso clínico de uma paciente do sexo feminino, portadora de um hemangioma no lábio superior esquerdo. Foram realizadas três aplicações do agente esclerosante Ethamolin no interior do tumor, até que ele regredisse o suficiente para ser removido cirurgicamente com maior segurança e eficiência. As aplicações com oleato de monoetanolamina proporcionaram a involução do hemangioma de forma rápida e segura, de modo a promover uma esclerose dos vasos tumorais, favorecendo a remoção cirúrgica.


The hemangioma is considered as a benign vascular neoplasm, characterized by a phase of rapid growth, with proliferation of endothelial cells, followed by gradual estabilization. The main complaint of patients with this neoplasm is related to aesthetics and, for this reason, sclerotherapy has been a good treatment option to obtain satisfactory aesthetic results. For this type of treatment, applications with 0.05 g/ml Monoethanolamine Oleate (Ethamolin), which causes regression of the lesion by fibrosis of the endothelial spaces, are used. In the present article a clinical case report of a female patient with a hemangioma in the upper left lip will be described. As a treatment, three applications of the Ethamolin sclerosing agent were performed inside the tumor until it regress to be excised with greater safety and efficiency. The applications with Monoethanolamine Oleate provided a quick hemangioma involution, in order to promote sclerosis of tumor vessels, favoring it surgical removal.


Subject(s)
Humans , Female , Middle Aged , Hemangioma/therapy , Lip Neoplasms/therapy , Oleic Acid/therapeutic use , Oral Surgical Procedures , Sclerosing Solutions/therapeutic use , Sclerotherapy , Vascular Malformations/drug therapy
18.
The Korean Journal of Gastroenterology ; : 86-89, 2018.
Article in Korean | WPRIM | ID: wpr-716128

ABSTRACT

Simple hepatic cysts are common benign liver lesions that usually have no malignant capability. They are generally asymptomatic and are often found incidentally by abdominal imaging procedures. Treatment becomes necessary, however, when huge hepatic cysts cause symptoms and develop complications, such as hemorrhage, adjacent organ damage, and infection. Several therapeutic options have been performed for symptomatic and huge cysts, including the aspiration of cystic fluid, infusion of various sclerosing agents, and surgical intervention. The optimal management of huge hepatic cysts is controversial and each option has its complications and limitations. This paper reports a case of a 66-year-old woman diagnosed with a simple hepatic cyst 2 years earlier, who was referred to hospital due to abdominal pain. The diagnosis was a huge hepatic cyst with symptoms by abdominal imaging studies. During the follow-up period, the huge cysts resolved spontaneously without treatment.


Subject(s)
Aged , Female , Humans , Abdominal Pain , Diagnosis , Follow-Up Studies , Hemorrhage , Liver , Sclerosing Solutions
19.
An. bras. dermatol ; 92(4): 484-491, July-Aug. 2017. tab, graf
Article in English | LILACS | ID: biblio-887013

ABSTRACT

Abstract: Background: Varicose veins and the complications of venous disease are common disorders in humans. Objective: To study the effects of bleomycin as a potential new sclerosing agent and its adverse events in treating varicose veins. Methods: Bleomycin-loaded liposomes 0.1ml was injected in the dorsal ear veins of white New Zealand rabbits. Sodium tetradecyl sulfate was used as a positive control. Normal saline was used as negative control. The blood vessels of the treated ears were photographed before and at one hour and two, eight and 45 days after treatment. Biopsies from the treated areas were obtained for histological examination. Blood samples were collected to determine any possible toxicity. Results: Bleomycin by itself was ineffective; therefore, liposomes were used as a vector to deliver bleomycin to the vein lumen. Subsequently, bleomycin started showing its sclerosing effects. Toxicity monitoring showed no apparent hematologic, pulmonary, hepatic or renal toxicities. This study revealed that bleomycin induced vasculitis, which led to vascular occlusion, which was observed on day 1 and day 8. No bleomycin-related injury was noted by histopathological examination of lung sections. The calculation of the lung/body weight coefficient indicated that edema was present in the experimental groups compared with the negative and positive controls. Study limitations: Relatively small number of experimental animals used. Conclusions: This study showed that bleomycin-loaded liposomes were able to induce vasculitis and vascular occlusion without any toxicity or complications. It might be useful, hence, to treat patients suffering from Varicose veins and other ectatic vascular diseases with this agent.


Subject(s)
Animals , Rabbits , Sclerosing Solutions/pharmacology , Sodium Tetradecyl Sulfate/administration & dosage , Varicose Veins/therapy , Bleomycin/pharmacology , Sclerotherapy/methods , Antibiotics, Antineoplastic/administration & dosage , Sclerosing Solutions/administration & dosage , Sclerosing Solutions/adverse effects , Vasculitis/chemically induced , Vasculitis/drug therapy , Veins/drug effects , Bleomycin/administration & dosage , Disease Models, Animal , Drug Evaluation, Preclinical , Injections, Intravenous , Liposomes
20.
Rev. Col. Bras. Cir ; 44(3): 308-313, mai.-jun. 2017. tab, graf
Article in Portuguese | LILACS | ID: biblio-896583

ABSTRACT

RESUMO A termoablação endovascular das veias safenas insuficientes com laser é descrita como uma técnica menos invasiva, com resultados semelhantes à cirurgia convencional, porém, com efeitos adversos menos frequentes. A técnica de escleroterapia com espuma de polidocanol ecoguiada vem sendo empregada com a mesma finalidade. A combinação de técnicas pode representar uma alternativa para pacientes mais graves, como os portadores de úlcera varicosa. Um equipamento de laser (denominado VELAS) foi desenvolvido no Centro de Pesquisas em Ótica e Fotônica da USP-São Carlos em convênio com a FMB-UNESP para termoablação endoluminal da veia safena insuficiente. Neste estudo apresentamos os resultados preliminares do uso do aparelho de laser VELAS (diodo MMO 980nm) na termoablação endovascular de veias safenas insuficientes, em portadores de úlcera venosa crônica, associado à complementação com espuma de polidocanol para o tratamento de varicosidades, após uma semana. Os desfechos analisados foram o tempo de cicatrização da úlcera venosa, oclusão das veias tratadas e eventos adversos relacionados aos tratamentos. Foram incluídos 12 pacientes portadores de insuficiência de veia safena e úlcera venosa crônica que aceitaram participar do projeto. Todos foram tratados em regime ambulatorial, com anestesia local e termoablação da veia safena insuficiente (VELAS). Após uma semana da cirurgia, as varicosidades foram esclerosadas com polidocanol espuma (técnica de Tessari). O equipamento laser VELAS nacional apresentou fácil manuseio, oclusão venosa total em 83,3% dos pacientes (em sete dias) e a associação das técnicas foi responsável por uma taxa de cicatrização de feridas de 83,3%, sem ocorrência de eventos adversos.


ABSTRACT The endovenous laser ablation (EVLA) of the insufficient saphenous vein has similar results to open conventional surgery, but less morbidity. The echo-guided polidocanol foam sclerotherapy technique has been used for the same purpose. The combined techniques may play a role for more severe diseases, such as those with varicose ulcers. An EVLA device (called VELAS) has been developed in the Optics and Photonics Research Center of USP-São Carlos in agreement with FMB-UNESP. In this study, we present the preliminary results of the VELAS device (MMO 980nm diode) in patients with chronic venous ulcer, associated with echo-guided polidocanol foam sclerotherapy for the treatment of varicosities. Primary outcomes were healing time of the venous ulcer, occlusion of the treated veins and treatment-related adverse events. We included 12 patients with insufficient saphenous vein and chronic venous ulcer. Initially, we treated all of them with thermoablation of the insufficient saphenous vein (VELAS), on an outpatient basis, with local anesthesia. After one week of the procedure, we sclerosed the varicosities with polidocanol foam (Tessari technique). The national VELAS device was easily handled. Total venous occlusion occurred in 83.3% of the patients (in seven days) and the association of the techniques was responsible for a wound healing rate of 83.3%, with no adverse events.


Subject(s)
Humans , Male , Female , Adult , Aged , Polyethylene Glycols/therapeutic use , Saphenous Vein , Sclerosing Solutions/therapeutic use , Venous Insufficiency/therapy , Sclerotherapy , Laser Therapy , Lasers, Semiconductor/therapeutic use , Endovascular Procedures/methods , Severity of Illness Index , Brazil , Treatment Outcome , Combined Modality Therapy , Polidocanol , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL